Magnesium glycinate and magnesium L-threonate are both ways to deliver supplemental magnesium, but they are sold with different expectations. Glycinate is usually chosen for tolerability and sleep-adjacent use. Threonate is marketed for brain delivery and cognition, with emerging sleep data. The first question is not which label sounds more advanced; it is whether supplemental magnesium is needed and whether the dose stays within safe supplemental limits.
Magnesium Glycinate vs Magnesium Threonate
Library metadata snapshot date: 2026-05-06.
Quick decision table
| Decision point | Magnesium glycinate | Magnesium L-threonate |
|---|---|---|
| Best fit | General magnesium repletion trial, evening relaxation, sleep quality support | Cognition or sleep trial when the user accepts higher cost and thinner evidence |
| Typical adult supplement range | 100-200 mg elemental magnesium per day to start | Product-specific; often 1-2 g magnesium L-threonate yielding lower elemental magnesium |
| Onset to judge | 1-4 weeks | 3-6 weeks in available trials |
| Evidence shape | Magnesium evidence overall plus newer bisglycinate sleep RCT data | Product-specific sleep and cognition RCTs, still limited |
| Main side effects to watch | Loose stool, nausea, sleepiness, low blood pressure in sensitive users | Headache, GI upset, sleep changes, cost with lower elemental magnesium |
| Medication timing concern | Separates from levothyroxine, tetracycline and quinolone antibiotics, bisphosphonates, and some minerals | Same magnesium separation concerns |
| Better first pick | If the goal is sleep or simple magnesium support | If the goal is a threonate-specific cognition or sleep experiment |
For most people, magnesium glycinate is the simpler first test. Magnesium threonate is a more specific hypothesis: maybe this form changes sleep or cognitive measures beyond what a lower-cost, well-tolerated magnesium form does.
Shared outcomes
Both forms contribute magnesium, a required mineral involved in muscle and nerve function, glucose metabolism, blood pressure regulation, and many enzyme systems. NIH's Office of Dietary Supplements notes that many people in the United States consume less magnesium than estimated average requirements, though frank deficiency is less common in otherwise healthy people. 1
Both forms are used in sleep stacks, stress stacks, and recovery stacks. Both can create attribution problems if started with melatonin, glycine, L-theanine, ashwagandha, or bedtime routine changes. Keep one variable at a time and use dose windows that do not collide with medications.
Both forms count toward the same supplemental magnesium upper intake level. NIH lists 350 mg per day as the adult tolerable upper intake level for magnesium from dietary supplements and medications, not including magnesium naturally present in food. That number is about GI side effects and safety at a population level; it is not a target dose. 1
Evidence differences
Magnesium as a sleep supplement has mixed evidence. A 2022 systematic review found observational links between magnesium status and sleep outcomes, but randomized trials were uncertain and limited. A 2021 meta-analysis of older adults with insomnia symptoms found that oral magnesium may improve some subjective sleep measures, with low to very low certainty. 2 3
Magnesium bisglycinate now has direct randomized placebo-controlled sleep data in healthy adults reporting poor sleep, which makes the glycinate family more than just a tolerability story. Still, one form-specific trial does not prove that every glycinate product improves sleep for every user. 4
Magnesium L-threonate has product-specific randomized trial data for adults with self-reported sleep problems and newer work on cognition and sleep. The brain-bioavailability claim is biologically interesting, but human outcomes remain the point. If a person pays more for threonate, the trial should measure something threonate is supposed to improve: sleep quality, daytime function, memory, or attention. 5
The evidence gap is direct comparison. There is no strong head-to-head body of evidence proving magnesium threonate beats magnesium glycinate for sleep, cognition, or general supplementation. Any such claim should be treated as uncertain until tested directly.
Dose and timing comparison
| Use case | Magnesium glycinate approach | Magnesium L-threonate approach |
|---|---|---|
| First exposure | 100 mg elemental magnesium with dinner or before bed | Half label dose with dinner or earlier evening |
| Sleep trial | 100-200 mg elemental magnesium 30-90 minutes before bed | Product label dosing, often split, tested for 3-6 weeks |
| Cognition trial | Not a strong acute cognition tool | Morning or split dosing if testing daytime cognition |
| GI-sensitive users | Take with food and avoid high first doses | Take with food and avoid high first doses |
| Medication separation | Separate by 2-6 hours depending on drug | Same separation |
Elemental magnesium is the number to track. A capsule may contain 1,000 mg magnesium glycinate but far less elemental magnesium. A threonate serving may look large by compound weight while delivering a modest elemental dose. Log both if the label shows both.
If the product causes loose stool, lower the dose or stop. Magnesium oxide and citrate are more famous for laxative effects, but any magnesium form can cause GI symptoms at the wrong dose for that person.
Safety and interactions
Magnesium can reduce absorption of several medications. NIH notes timing concerns with tetracycline and quinolone antibiotics, bisphosphonates, and levothyroxine. The exact separation window depends on the medication, so the label and pharmacist should govern the schedule. 1
People with kidney disease need clinician guidance before supplemental magnesium because impaired kidney function can raise the risk of magnesium accumulation. People taking diuretics, proton pump inhibitors, heart medications, or blood-pressure medications should also review magnesium use with a clinician.
Magnesium can make some people sleepy, relaxed, or lightheaded. That may be welcome at bedtime and unacceptable before driving, machinery, or safety-critical work. First doses belong on low-demand evenings.
Who should avoid either option
| Person or context | Avoid magnesium glycinate | Avoid magnesium L-threonate |
|---|---|---|
| Kidney disease or reduced kidney function | Avoid unless clinician-directed | Avoid unless clinician-directed |
| Taking levothyroxine, quinolone or tetracycline antibiotics, bisphosphonates, or mineral-sensitive drugs | Use only with correct separation guidance | Use only with correct separation guidance |
| Already getting high supplemental magnesium from multiple products | Avoid duplicate dosing | Avoid duplicate dosing |
| Unexplained diarrhea or GI disease flare | Avoid until stable | Avoid until stable |
| Wants a proven acute nootropic | Poor fit | Evidence is too thin for that promise |
| Budget-sensitive user | Usually the better value | Often poor value unless testing a specific hypothesis |
The main avoidable mistake is duplicate magnesium: sleep powder, multivitamin, electrolyte drink, and capsules all adding up while the user only notices the branded bedtime product.
N-of-1 testing protocol
| Phase | Duration | What to do | Decision rule |
|---|---|---|---|
| Baseline | 14 days | Track bedtime, wake time, sleep latency, awakenings, stool quality, resting heart rate, alcohol, caffeine, and training load | Start only if sleep timing is stable enough to compare |
| Glycinate trial | 3-4 weeks | Take the same elemental dose at the same evening time | Keep only if sleep or recovery metrics improve without GI cost |
| Washout | 1-2 weeks | Stop and keep tracking | If the benefit remains unchanged, magnesium may not be the driver |
| Threonate trial | 3-6 weeks | Use one product at label dose or lower, keeping other sleep aids stable | Keep only if it beats glycinate or solves a different metric |
| Review | 1 day | Compare benefit, side effects, cost, and medication burden | Keep the lowest-risk, lowest-cost effective option or neither |
Use risk checks for duplicate magnesium before starting. If a medication requires separation, put the supplement in the schedule only after the medication window is protected.
In Unfair
Log the exact magnesium form, elemental magnesium, compound weight, dose time, medication separation, and sleep metrics. If the goal is sleep, pair the supplement entry with sleep latency and wake-after-sleep-onset notes. If the goal is cognition, use a repeatable task rather than a vague "brain feels better" note.
See also: Sleep Architecture Optimization, Understanding Dose Windows and Cycles, and Supplement Medication Interactions.
References
This article is for education only and does not substitute for professional medical advice. Consult your clinician or pharmacist before making changes to your supplement routine.
National Institutes of Health, Office of Dietary Supplements. Magnesium: Health Professional Fact Sheet. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/
↩Mah J, Pitre T. Oral magnesium supplementation for insomnia in older adults: A systematic review and meta-analysis. BMC Complement Med Ther. 2021;21:125. https://pubmed.ncbi.nlm.nih.gov/33865376/
↩Arab A, Rafie N, Amani R, Shirani F. The role of magnesium in sleep health: A systematic review of available literature. Biol Trace Elem Res. 2023;201(1):121-128. https://pubmed.ncbi.nlm.nih.gov/35184264/
↩Schuster J, Cycelskij I, Lopresti A, Hahn A. Magnesium bisglycinate supplementation in healthy adults reporting poor sleep: A randomized, placebo-controlled trial. Nat Sci Sleep. 2025;17:2027-2040. https://pubmed.ncbi.nlm.nih.gov/40918053/
↩Held K, Antonijevic I, Kunz S, et al. Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: A randomized controlled trial. Sleep Med X. 2024;8:100121. https://pmc.ncbi.nlm.nih.gov/articles/PMC11381753/
↩